Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Vandana Singh

FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump

In December 2021, Baxter International Inc (NYSE:BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps. The FDA has identified this as a Class I recall, the most serious type of recall.

The recall pertains to Baxter's Spectrum V8 and Spectrum IQ infusion pumps used in clinical settings to deliver controlled amounts of fluids such as pharmaceutical drugs, blood & blood products, and other required patient therapies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.